1. Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events. (8th February 2021) Authors: Astarita, A; Mingrone, G; Airale, L; Vallelonga, F; Catarinella, C; Cesareo, M; Leone, D; Bruno, G; Maffei, I; Veglio, F; Milan, A Journal: European heart journal Issue: Volume 22(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Echocardiographic systolic and diastolic function alterations in multiple myeloma patients treated with Carfilzomib. (8th February 2021) Authors: Mingrone, G; Astarita, A; Maffei, I; Cesareo, M; Airale, L; Bruno, G; Vallelonga, F; Catarinella, C; Salvini, M; Bringhen, S; Gay, F; Veglio, F; Milan, A Journal: European heart journal Issue: Volume 22(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗